Home›Companies›Healthcare›Telesair

Telesair, Inc.

Telesair makes oxygen therapy devices for patients receiving respiratory care.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Mar 18, 2026·Suggest an edit

About Telesair

Telesair is a private company based in Irvine, California. It has reported $25,800,737 raised in two offerings on Form D since February 2023. Its chief executive is Dongping Lin.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 4, 2026Mar 18, 2026$2,955,791of $6.0M target12$246KEquityRule 506(b)Form D ↗
Sep 1, 2022Feb 22, 2023$22,844,946fully sold31$736KEquityRule 506(b)Form D ↗
Total, two offerings$25,800,737

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Telesair's Form D filed Mar 18, 2026.

TL
Tyler Li
Director
KW
Ken Wang
Executive officer and director
DL
Dongping Lin
Chief Executive Officer and director
MM
Matt Margolies
President and COO, director
VL
Vincent Luo
Director

Earlier filings also listed Yong Liu (ceo and director, last listed Feb 2023), Xiansheng Duan (director, last listed Feb 2023), Qing Wang (director, last listed Feb 2023), Jing Zhang (director, last listed Feb 2023) and Bo Li (director, last listed Feb 2023).

Sources

  1. SECTelesair, Inc. filing history
  2. CompanyTelesair team